Efficacy of subsequent-abemaciclib treatment after disease progression on palbociclib combined with endocrine therapy in patients with ER-positive HER2-negative metastatic breast cancer

被引：0
|
作者：
Seki, Hirohito
Nakai, Taketo
Shimizu, Ken
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P5-02-49
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-02-49
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The impact of intratumoral heterogeneity on the prognosis of ER-positive/HER2-negative breast cancer
    Oikawa, Masahiro
    Ishida, Mayumi
    Nakamura, Yoshiaki
    Nishimura, Sumiko
    Koga, Chinami
    Saruwatari, Akihiro
    Igawa, Akiko
    Akiyoshi, Sayuri
    Koi, Yumiko
    Ohno, Shinji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
    Pascual, Javier
    Gil-Gil, Miguel
    Proszek, Paula
    Zielinski, Christoph
    Reay, Alistair
    Ruiz-Borrego, Manuel
    Cutts, Rosalind
    Ciruelos Gil, Eva M.
    Feber, Andrew
    Munoz-Mateu, Montserrat
    Swift, Claire
    Bermejo, Begona
    Herranz, Jesus
    Margeli Vila, Mireia
    Anton, Antonio
    Kahan, Zsuzsanna
    Csoeszi, Tibor
    Liu, Yuan
    Fernandez-Garcia, Daniel
    Garcia-Murillas, Isaac
    Hubank, Michael
    Turner, Nicholas C.
    Martin, Miguel
    CLINICAL CANCER RESEARCH, 2023, 29 (20) : 4166 - 4177
  • [43] Anthracycline-free Neo-adjuvant Treatment for Patients with ER-positive, HER2-negative Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (03) : 248 - 248
  • [44] Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients’ experiences
    Helena Harder
    Rachel Starkings
    Lesley Fallowfield
    Shirley May
    Valerie Shilling
    Supportive Care in Cancer, 2025, 33 (5)
  • [45] The efficacy and safety of palbociclib combined with endocrine therapy in patients with hormone receptor-positive HER2-negative advanced breast cancer: a multi-center retrospective analysis
    Zhang, Linhui
    Song, Guohong
    Shao, Bin
    Xu, Ling
    Xiao, Yu
    Wang, Mopei
    Sumou, Ingrid Karmane
    Zhang, Yan
    Liang, Xu
    Jiang, Hanfang
    Li, Huiping
    ANTI-CANCER DRUGS, 2022, 33 (01) : E635 - E643
  • [46] Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study
    Tolaney, Sara M.
    Beeram, Muralidhar
    Beck, J. Thaddeus
    Conlin, Alison
    Dees, E. Claire
    Puhalla, Shannon L.
    Rexer, Brent N.
    Burris, Howard A., III
    Jhaveri, Komal
    Helsten, Teresa
    Becerra, Carlos
    Kalinsky, Kevin
    Moore, Kathleen N.
    Manuel, Allison M.
    Lithio, Andrew
    Price, Gregory L.
    Chapman, Sonya C.
    Litchfield, Lacey M.
    Goetz, Matthew P.
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [47] Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer
    Esther S. Kim
    Lesley J. Scott
    Targeted Oncology, 2017, 12 : 373 - 383
  • [48] Palbociclib: A Review in HR-Positive, HER2-Negative, Advanced or Metastatic Breast Cancer
    Kim, Esther S.
    Scott, Lesley J.
    TARGETED ONCOLOGY, 2017, 12 (03) : 373 - 383
  • [49] Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
    Schettini, Francesco
    De Santo, Irene
    Rea, Carmen G.
    Viggiani, Martina
    Buono, Giuseppe
    De Angelis, Carmine
    Cardalesi, Cinzia
    Lauria, Rossella
    Giuliano, Mario
    Forestieri, Valeria
    Thomas, Guglielmo
    Maione, Pierfrancesco
    Limite, Gennaro
    Accurso, Antonello
    Malorni, Luca
    De Placido, Sabino
    Arpino, Grazia
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (05) : 456 - 460
  • [50] FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    Charlab, Rosane
    Chen, Wei
    Palmby, Todd
    Tilley, Amy
    Zirkelbach, Jeanne Fourie
    Yu, Jingyu
    Liu, Qi
    Zhao, Liang
    Crich, Joyce
    Chen, Xiao Hong
    Hughes, Minerva
    Bloomquist, Erik
    Tang, Shenghui
    Sridhara, Rajeshwari
    Kluetz, Paul G.
    Kim, Geoffrey
    Ibrahim, Amna
    Pazdur, Richard
    Cortazar, Patricia
    CLINICAL CANCER RESEARCH, 2015, 21 (21) : 4760 - 4766
12345